Noventra Pharma | Retatrutide 64mg | Research Compound Peptide Pen
High-Strength Triple Receptor Metabolic Research Compound
Retatrutide is an investigational peptide studied for its multi-receptor activity across GLP-1, GIP, and glucagon pathways.
It is widely referenced in scientific research exploring complex metabolic signalling, energy regulation mechanisms, and multi-pathway peptide interactions.
Developed as a high-strength 64mg research compound, this formulation is designed for advanced laboratory investigation where extended receptor activity and peptide behaviour profiling are of interest.
Key Benefits – Noventra Pharma Retatrutide 64mg Peptide Pen
• Triple receptor research compound targeting GLP-1, GIP, and glucagon pathways
• Investigated in metabolic signalling and energy regulation research models
• Of interest in multi-pathway peptide interaction studies
• High-strength 64mg research formulation for advanced investigation
• Long-acting peptide profile studied in extended activity research models
• Pre-filled pen format designed for consistent laboratory handling
• High-purity compounded formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
